Viemed Healthcare, Inc. (VMD)
Stock Price:
$8.79 USD
-0.73 (-7.67%)
Updated Oct 26, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
343.55M |
| Revenue (ttm) |
103.93M |
| Net Income (ttm) |
28.21M |
| Shares Out |
39.08M |
| EPS (ttm) |
0.25 |
| PE Ratio |
35.16 |
| Forward PE |
19.38 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 26, 2020 |
| Last Price |
$8.79 |
| Previous Close |
$9.52 |
| Change ($) |
-0.73 |
| Change (%) |
-7.67% |
| Day's Open |
9.53 |
| Day's Range |
8.78 - 9.55 |
| Day's Volume |
371,612 |
| 52-Week Range |
6.13 - 11.98 |
More Stats
| Market Cap |
343.55M |
| Enterprise Value |
329.36M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
39.08M |
| Float |
34.88M |
| EPS (basic) |
0.74 |
| EPS (diluted) |
0.25 |
| FCF / Share |
0.76 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
2.84% |
| FCF Yield |
8.50% |
| Payout Ratio |
n/a |
| Shares Short |
1.13M |
| Short Ratio |
4.63 |
| Short % of Float |
3.23% |
| Beta |
0.68 |
| PE Ratio |
35.16 |
| Forward PE |
19.38 |
| P/FCF Ratio |
11.77 |
| PS Ratio |
3.31 |
| PB Ratio |
5.23 |
| Revenue |
103.93M |
| Operating Income |
18.98M |
| Net Income |
28.21M |
| Free Cash Flow |
29.20M |
| Net Cash |
14.20M |
| Net Cash / Share |
0.36 |
| Gross Margin |
51.63% |
| Operating Margin |
18.26% |
| Profit Margin |
27.10% |
| FCF Margin |
28.10% |
| ROA |
11.10% |
| ROE |
52.34% |
| ROIC |
33.80% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (4)
| Buy |
3 |
| Overweight |
1 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$12.71*
(44.60% upside)
Low
11.0
Current: $8.79
High
15.0
Target: 12.71
*Average 12-month price target from 4 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 |
|---|
| Revenue | 80.26 | 64.46 | 46.93 |
| Revenue Growth | 24.5% | 37.37% | - |
| Gross Profit | 56.01 | 47.78 | 34.62 |
| Operating Income | 8.75 | 10.06 | 8.62 |
| Net Income | 8.53 | 9.51 | 8.18 |
| Shares Outstanding | 37.72 | 37.89 | 37.91 |
| Earnings Per Share | 0.21 | 0.24 | 0.22 |
| EPS Growth | -12.5% | 9.09% | - |
| Operating Cash Flow | 19.09 | 22.37 | 12.02 |
| Capital Expenditures | -12.81 | -5.30 | -3.57 |
| Free Cash Flow | 6.28 | 17.07 | 8.45 |
| Cash & Equivalents | 13.36 | 10.41 | 5.10 |
| Total Debt | 19.51 | 3.43 | 5.18 |
| Net Cash / Debt | -6.16 | 6.99 | -0.08 |
| Assets | 82.60 | 53.65 | 37.69 |
| Liabilities | 38.90 | 21.08 | 13.95 |
| Book Value | 43.70 | 32.57 | 23.74 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Viemed Healthcare, Inc. |
| Country |
United States |
| Employees |
459 |
| CEO |
Casey Hoyt |
Stock Information
| Ticker Symbol |
VMD |
| Stock Exchange |
NASDAQ |
| Sector |
Healthcare |
| Industry |
Medical Devices |
| Unique Identifier |
NASDAQ: VMD |
Description
Viemed Healthcare, through its subsidiaries, provides in-home durable medical equipment and health care solutions to patients in the United States. The company offers respiratory services and related equipment, including non-invasive ventilators; bi-level, continuous, and automatic continuous positive airway pressure (PAP) machines; and oxygen units, as well as services of respiratory therapists; and respiratory disease management, neuromuscular care, and oxygen therapy services. It also provides in-home sleep apnea testing services to determine the existence of sleep apnea at home. In addition, the company leases non-invasive and invasive ventilators, PAP machines, percussion vests, oxygen concentrator units, and respiratory equipment, as well as sells medical equipment and/or patient medical services. Further, it provides therapy and counseling to patients in their homes using its technology. The company was founded in 2006 and is headquartered in Lafayette, Louisiana.